The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates
Open Access
- 1 November 2014
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 28 (6) , 235-241
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- State of the Art in Platelet Function TestingTransfusion Medicine and Hemotherapy, 2013
- Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in miceBlood, 2012
- Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV LightTransfusion Medicine and Hemotherapy, 2011
- Dose of Prophylactic Platelet Transfusions and Prevention of HemorrhageNew England Journal of Medicine, 2010
- Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood productsBiologicals, 2010
- Protein synthesis by platelets: historical and new perspectivesJournal of Thrombosis and Haemostasis, 2009
- Quantitative Analysis of DNA Interstrand Cross-Links and Monoadducts Formed in Human Cells Induced by Psoralens and UVA IrradiationAnalytical Chemistry, 2008
- The hazards of blood transfusion in historical perspectiveBlood, 2008
- Effects of intercept pathogen inactivation on platelet function as analysed by free oscillation rheometryTransfusion and Apheresis Science, 2008
- The Clearance Mechanism of Chilled Blood PlateletsCell, 2003